News
Empagliflozin in the Treatment of Patients with Chronic Heart Failure
Unlike other antidiabetics, sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization due to heart failure and the risk of severe renal events in patients with type 2 diabetes mellitus. The efficacy of the SGLT2 inhibitor empagliflozin directly in the treatment of patients with chronic heart failure with reduced ejection fraction was evaluated in the EMPEROR-Reduced clinical study, the recently published results of which we summarize in the following article.
Modern Physical Therapy for Hemophiliacs
Today's physical therapists working with hemophiliacs find themselves in a unique situation - far…
Impact of Physiotherapy and Sports Activities on the Results of Movement Tests in Children with Hemophilia
At the 9th Hemophilia Academy, held online from October 5-7 in Budapest, a lecture by Mgr. Marie…
Compressive Therapy in Wound Treatment: Which Aids to Choose and How to Use Them Correctly?
If a patient is dealing with a chronic wound, it is necessary to support its healing with proper…
How to Properly Treat Frostbite?
Frostbite, or congelation, is defined as an acute condition involving damage to the skin and…
Prognostic Model MSKCC in Patients with Metastatic Renal Carcinoma Treated in 1st Line with Sunitinib
A study by Czech authors published in 2020 demonstrated the usefulness of the MSKCC (Memorial Sloan…
Treatment of COPD in Individuals with Alpha-1 Antitrypsin Deficiency
A mutation in the gene for alpha-1 antitrypsin (AAT), leading to its deficiency (AATD), causes…
Can the Treatment of Hypertension Prevent Recurrence of Atrial Fibrillation?
Atrial fibrillation (Afib) is the most common serious heart rhythm disorder and is responsible for…
Reduction of Risk of Hospitalizations for Heart Failure in Type 2 Diabetics
The EMPA-REG OUTCOME study already in 2015 highlighted one of the benefits of the sodium-glucose…
Recommendations for Substitution Therapy with Immunoglobulins in Hemato-oncological Patients with Secondary Immunodeficiency – Expert Consensus According to the DELPHI Methodology
Substitution therapy with immunoglobulins is used not only for patients with primary immunodeficiencies....
Conferences
News from the world of medicine
All conferences
Popular this week
- Where did COVID come from? Are infected animals or a lab leak to blame for the pandemic?
- Target blood pressure values in heart failure
- BENIGN DERMATOSIS OF PENIS
- Hypercalcemia may be the first sign of multiple myeloma, but not only that
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?